Gathering life energy
Caring for human health

OEC    Mail    |

搜索
Search
Stock Code:603520
Check category
/
/
Zhu Jielong, deputy director of Shanghai Jinshan Market Supervision and Administration Bureau, visited our company

Zhu Jielong, deputy director of Shanghai Jinshan Market Supervision and Administration Bureau, visited our company

  • Categories:News
  • Author:Chenshihong
  • Origin:
  • Time of issue:2020-04-02
  • Views:0

(Summary description)

Zhu Jielong, deputy director of Shanghai Jinshan Market Supervision and Administration Bureau, visited our company

(Summary description)

  • Categories:News
  • Author:Chenshihong
  • Origin:
  • Time of issue:2020-04-02
  • Views:0
Information

On April 2, Zhu Jielong, deputy director of the Shanghai Jinshan District Market Supervision Administration, and his entourage visited Shanghai Stellite Pharmaceutical Co., Ltd. for research and guidance, to understand the company’s production and operation status under the epidemic prevention and control, intellectual property rights and drug quality management issues and needs , And arranged for leaders of relevant departments to introduce to our company the support policies on intellectual property rights and quality management issued by the government and relevant departments. The company's executive vice president Lu Wenjun and heads of related departments participated in the reception.

 

At the meeting, the company's executive vice president Lu Wenjun introduced the company's operating conditions during the epidemic; Chen Shihong, the company's intellectual property director, reported the company's basic overview, product planning, registration progress, and intellectual property rights to the leaders; The leaders of the Section conducted targeted communication with the company on intellectual property and quality management, put forward specific work suggestions to the company, and introduced in detail the local policies on intellectual property and quality management.

 

Deputy Director Zhu Jielong fully affirmed our company’s work in production, operation and intellectual property management, and pointed out that as a pharmaceutical company in the field of contrast agent R&D and production, technological innovation and intellectual property protection are particularly important; he hopes that companies can be advanced in benchmarking. Look for the gap, further strengthen the enterprise's intellectual property and quality management, and enhance the enterprise's core competitiveness.

 

After the epidemic was brought under control, the competent authorities came to our company in time to guide work and preach policies, which greatly boosted the morale of our employees. We deeply feel the professional management and service level of the competent authorities, as well as the superior business environment of Jinshan District and Jinshan Industrial Zone. This has strengthened our company's determination to overcome difficulties and achieve business goals. At the same time, the direction of our company's work in intellectual property and quality management has become clearer, and we strive to make relevant work more precise and detailed, and escort the normal operation of the company.

Scan the QR code to read on your phone

Related documents

There is currently no content to display
Please add data record on website background.